Author: admin

Osteosarcoma Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | Pfizer Inc., Recordati Group, Takeda Pharma, Amgen, Baxter, Bayer AG, Hikma Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Osteosarcoma pipeline constitutes 25+ key companies continuously working towards developing 30+ Osteosarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Osteosarcoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

“Osteosarcoma Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Osteosarcoma Market.

 

Some of the key takeaways from the Osteosarcoma Pipeline Report:

  • Companies across the globe are diligently working toward developing novel Osteosarcoma treatment therapies with a considerable amount of success over the years. 

  • Osteosarcoma companies working in the treatment market are Dana-Farber Cancer Institute, MedPacto, Inc., K-Group, Beta, Inc., H. Lee Moffitt Cancer Center, Hansoh BioMedical R&D Company, Ipsen, UNICANCER, Adaptimmune, M.D. Anderson Cancer Center, and others, are developing therapies for the Osteosarcoma treatment 

  • Emerging Osteosarcoma therapies in the different phases of clinical trials are- Olaparib, Vactosertib, ZN-c3, Nivolumab, HS-20093, Cabozantinib, cisplatin, Afamitresgene autoleucel, Aldesleukin, and others are expected to have a significant impact on the Osteosarcoma market in the coming years.   

  • In April 2024, Lisata Therapeutics has received orphan drug designation from the FDA for its investigational agent LSTA1 (CEND-1) to treat pediatric and adult patients with osteosarcoma.

 

Osteosarcoma Overview

Osteosarcoma is a type of bone cancer that originates in the cells that form bones. It is the most common type of cancer that starts in the bones, primarily affecting children, teenagers, and young adults.

 

Get a Free Sample PDF Report to know more about Osteosarcoma Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/osteosarcoma-pipeline-insight

 

Emerging Osteosarcoma Drugs Under Different Phases of Clinical Development Include:

  • Olaparib: Dana-Farber Cancer Institute

  • Vactosertib: MedPacto, Inc.

  • ZN-c3: K-Group, Beta, Inc.

  • Nivolumab: H. Lee Moffitt Cancer Center

  • HS-20093: Hansoh BioMedical R&D Company

  • Cabozantinib: Ipsen

  • cisplatin: UNICANCER

  • Afamitresgene autoleucel: Adaptimmune

  • Aldesleukin: M.D. Anderson Cancer Center

 

Osteosarcoma Route of Administration

Osteosarcoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

  • Oral

  • Parenteral

  • Intravenous

  • Subcutaneous

  • Topical

 

Osteosarcoma Molecule Type

Osteosarcoma Products have been categorized under various Molecule types, such as

  • Recombinant fusion proteins

  • Small molecule

  • Monoclonal antibody

  • Peptide

  • Polymer

  • Gene therapy

 

Osteosarcoma Pipeline Therapeutics Assessment

  • Osteosarcoma Assessment by Product Type

  • Osteosarcoma By Stage and Product Type

  • Osteosarcoma Assessment by Route of Administration

  • Osteosarcoma By Stage and Route of Administration

  • Osteosarcoma Assessment by Molecule Type

  • Osteosarcoma by Stage and Molecule Type

 

DelveInsight’s Osteosarcoma Report covers around 30+ products under different phases of clinical development like

  • Late-stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I)

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

  • Route of Administration

 

Further Osteosarcoma product details are provided in the report. Download the Osteosarcoma pipeline report to learn more about the emerging Osteosarcoma therapies

 

Some of the key companies in the Osteosarcoma Therapeutics Market include:

Key companies developing therapies for Osteosarcoma are – Pfizer Inc., Recordati Group, Takeda Pharmaceutical Company, Amgen, Baxter, Bayer AG, Hikma Pharmaceuticals, Johnson & Johnson, Novartis AG, Debiopharm, Eli Lilly and Company, Atlanthera, Spectrum Pharmaceuticals Inc., and others.

 

Osteosarcoma Pipeline Analysis:

The Osteosarcoma pipeline report provides insights into 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Osteosarcoma with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Osteosarcoma Treatment.

  • Osteosarcoma key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Osteosarcoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Osteosarcoma market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Osteosarcoma drugs and therapies

 

Osteosarcoma Pipeline Market Strengths

  • The rise in the incidence of osteosarcoma

  • Improvement of treatment over the years along with newly updated guidelines

  • Various immunotherapies such as PD-L1 inhibitors and CTLA4 inhibitors are under investigation for osteosarcoma

 

Osteosarcoma Pipeline Market Opportunities

  • Genetic and other disease-related biomarkers are not much explored in drug development

  • Lack of approved drugs for chemo-resistant disease and maintenance therapy

 

Scope of Osteosarcoma Pipeline Drug Insight    

  • Coverage: Global

  • Key Osteosarcoma Companies: Dana-Farber Cancer Institute, MedPacto, Inc., K-Group, Beta, Inc., H. Lee Moffitt Cancer Center, Hansoh BioMedical R&D Company, Ipsen, UNICANCER, Adaptimmune, M.D. Anderson Cancer Center, and others

  • Key Osteosarcoma Therapies: Olaparib, Vactosertib, ZN-c3, Nivolumab, HS-20093, Cabozantinib, cisplatin, Afamitresgene autoleucel, Aldesleukin, and others

  • Osteosarcoma Therapeutic Assessment: Osteosarcoma current marketed and Osteosarcoma emerging therapies

  • Osteosarcoma Market Dynamics: Osteosarcoma market drivers and Osteosarcoma market barriers 

 

Request for Sample PDF Report for Osteosarcoma Pipeline Assessment and clinical trials

 

Table of Contents

1. Osteosarcoma Report Introduction

2. Osteosarcoma Executive Summary

3. Osteosarcoma Overview

4. Osteosarcoma- Analytical Perspective In-depth Commercial Assessment

5. Osteosarcoma Pipeline Therapeutics

6. Osteosarcoma Late Stage Products (Phase II/III)

7. Osteosarcoma Mid Stage Products (Phase II)

8. Osteosarcoma Early Stage Products (Phase I)

9. Osteosarcoma Preclinical Stage Products

10. Osteosarcoma Therapeutics Assessment

11. Osteosarcoma Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Osteosarcoma Key Companies

14. Osteosarcoma Key Products

15. Osteosarcoma Unmet Needs

16 . Osteosarcoma Market Drivers and Barriers

17. Osteosarcoma Future Perspectives and Conclusion

18. Osteosarcoma Analyst Views

19. Appendix

20. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Osteosarcoma Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | Pfizer Inc., Recordati Group, Takeda Pharma, Amgen, Baxter, Bayer AG, Hikma Pharma

Atrial Fibrillation Pipeline Report 2024: Drug Approvals and Clinical Trials Progress | Bayer, Johnson and Johnson, Bristol Myers-Squibb, Daiichi Sankyo, Pfizer, Anthos Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atrial Fibrillation pipeline constitutes 15+ key companies continuously working towards developing 15+ Atrial Fibrillation treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Atrial Fibrillation Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

“Atrial Fibrillation Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Atrial Fibrillation Market.

 

Some of the key takeaways from the Atrial Fibrillation Pipeline Report: 

  • Companies across the globe are diligently working toward developing novel Atrial Fibrillation treatment therapies with a considerable amount of success over the years. 

  • Atrial Fibrillation companies working in the treatment market are Thryv Therapeutics Inc., Vivasc Therapeutics, Verseon, HUYA Bioscience, Novartis, AbbVie, Bayer AG, InCarda Therapeutics, Inc., and others, are developing therapies for the Atrial Fibrillation treatment 

  • Emerging Atrial Fibrillation therapies in the different phases of clinical trials are- Research programme, CTP-Amio, VE 1902, HBI-3000, HSY 244, AGN-151607, Asundexian, Inrhythm, and others are expected to have a significant impact on the Atrial Fibrillation market in the coming years.   

  • In December 2023, A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study comparing the effectiveness and safety of the oral FXIa inhibitor Asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 and older with atrial fibrillation at risk for stroke (OCEANIC-AF) was started by Bayer.

 

Atrial Fibrillation Overview

Atrial Fibrillation (AF) is an irregular or trembling heartbeat that raises the risk of blood clots, stroke, heart failure, and other issues related to the heart. The two upper chambers of the heart, known as the atria, beat erratically and chaotically during atrial fibrillation, not in time with the lower chambers, known as the ventricles.

 

Get a Free Sample PDF Report to know more about Atrial Fibrillation Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/atrial-fibrillation-pipeline-insight

 

Emerging Atrial Fibrillation Drugs Under Different Phases of Clinical Development Include:

  • Research programme: Thryv Therapeutics Inc.

  • CTP-Amio: Vivasc Therapeutics

  • VE 1902: Verseon

  • HBI-3000: HUYA Bioscience

  • HSY 244: Novartis

  • AGN-151607: AbbVie

  • Asundexian: Bayer AG

  • Inrhythm: InCarda Therapeutics, Inc.

 

Atrial Fibrillation Route of Administration

Atrial Fibrillation pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 

  • Intravenous

  • Subcutaneous

  • Oral

  • Intramuscular

 

Atrial Fibrillation Molecule Type

Atrial Fibrillation Products have been categorized under various Molecule types, such as

  • Monoclonal antibody

  • Small molecule

  • Peptide

 

Atrial Fibrillation Pipeline Therapeutics Assessment

  • Atrial Fibrillation Assessment by Product Type

  • Atrial Fibrillation By Stage and Product Type

  • Atrial Fibrillation Assessment by Route of Administration

  • Atrial Fibrillation By Stage and Route of Administration

  • Atrial Fibrillation Assessment by Molecule Type

  • Atrial Fibrillation by Stage and Molecule Type

 

DelveInsight’s Atrial Fibrillation Report covers around 15+ products under different phases of clinical development like

  • Late-stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I)

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

  • Route of Administration

 

Further Atrial Fibrillation product details are provided in the report. Download the Atrial Fibrillation pipeline report to learn more about the emerging Atrial Fibrillation therapies

 

Some of the key companies in the Atrial Fibrillation Therapeutics Market include:

Key companies developing therapies for Atrial Fibrillation are – Bayer, Johnson and Johnson, Bristol Myers-Squibb, Daiichi Sankyo, Pfizer, Anthos Therapeutics, Cadrenal Therapeutics, Boehringer Ingelheim, InCarda Therapeutics, and others.

 

Atrial Fibrillation Pipeline Analysis:

The Atrial Fibrillation pipeline report provides insights into 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Atrial Fibrillation with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Atrial Fibrillation Treatment.

  • Atrial Fibrillation key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Atrial Fibrillation Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Atrial Fibrillation market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Atrial Fibrillation drugs and therapies

 

Atrial Fibrillation Pipeline Market Drivers

  • Rising prevalence of Atrial fibrillation, increase in the Adoption of Advanced Technologies are some of the important factors that are fueling the Atrial Fibrillation Market.

 

Atrial Fibrillation Pipeline Market Barriers

  • However, complications associated with the use of Atrial fibrillation drugs, lack of awareness regarding medical therapy in underdeveloped and developing regions and other factors are creating obstacles in the Atrial Fibrillation Market growth.

 

Scope of Atrial Fibrillation Pipeline Drug Insight    

  • Coverage: Global

  • Key Atrial Fibrillation Companies: Thryv Therapeutics Inc., Vivasc Therapeutics, Verseon, HUYA Bioscience, Novartis, AbbVie, Bayer AG, InCarda Therapeutics, Inc., and others

  • Key Atrial Fibrillation Therapies: Research programme, CTP-Amio, VE 1902, HBI-3000, HSY 244, AGN-151607, Asundexian, Inrhythm, and others

  • Atrial Fibrillation Therapeutic Assessment: Atrial Fibrillation current marketed and Atrial Fibrillation emerging therapies

  • Atrial Fibrillation Market Dynamics: Atrial Fibrillation market drivers and Atrial Fibrillation market barriers 

 

Request for Sample PDF Report for Atrial Fibrillation Pipeline Assessment and clinical trials

 

Table of Contents

1. Atrial Fibrillation Report Introduction

2. Atrial Fibrillation Executive Summary

3. Atrial Fibrillation Overview

4. Atrial Fibrillation- Analytical Perspective In-depth Commercial Assessment

5. Atrial Fibrillation Pipeline Therapeutics

6. Atrial Fibrillation Late Stage Products (Phase II/III)

7. Atrial Fibrillation Mid Stage Products (Phase II)

8. Atrial Fibrillation Early Stage Products (Phase I)

9. Atrial Fibrillation Preclinical Stage Products

10. Atrial Fibrillation Therapeutics Assessment

11. Atrial Fibrillation Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Atrial Fibrillation Key Companies

14. Atrial Fibrillation Key Products

15. Atrial Fibrillation Unmet Needs

16 . Atrial Fibrillation Market Drivers and Barriers

17. Atrial Fibrillation Future Perspectives and Conclusion

18. Atrial Fibrillation Analyst Views

19. Appendix

20. About DelveInsight

 

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Atrial Fibrillation Pipeline Report 2024: Drug Approvals and Clinical Trials Progress | Bayer, Johnson and Johnson, Bristol Myers-Squibb, Daiichi Sankyo, Pfizer, Anthos Therapeutics

Telf AG: a new level of resource management and business strategies in a mobile game

Prepare for a deeper dive into the world of business automation with the upcoming release of the latest version of Telf AG. This widely popular mobile game combines elements of business strategy and resource management, providing players with unique opportunities to create a successful business empire.

Coming soon to the App Store and Google Play, the new version of Telf AG will introduce many innovative features, improved graphics and exciting mini-games that will take the gaming experience to a whole new level.

Meet the new game Telf AG: Step towards creating a business empire

In Telf AG, players will take on the role of an ambitious young entrepreneur who will have to build a thriving business from scratch. Starting with small operations and gradually expanding their holdings, players will be able to discover new territories on the map, manage personnel and optimize resources to achieve business success.

New additions and improvements to the game Telf AG

  • Dive into the exciting world of office management with new dynamic employee roles and an expanded statistics system. The game allows you to assign tasks to workers, develop their professional skills and optimize business operations with an advanced resource trading system. These features provide a deeper and richer gaming experience with Telf AG, making business management even more realistic and exciting.
  • You will find entertaining mini-games that add variety and fun to the gameplay. For example, a new quiz featuring 50 facts about Telf AG and its complex ores will be a great way to test your knowledge and learn something new about the world of the game.
  • In addition, daily business tasks provide additional opportunities to develop your character and discover new locations. By completing these tasks, you will move forward, improving your management skills and increasing your character level. These updates create a more dynamic and exciting gaming environment, where every day brings new challenges and opportunities.

Witness the evolution of your city in Telf AG

Immerse yourself in the exciting process of transforming a quiet town into a vibrant metropolis in the game Telf AG. Your city will attract talent and increase business productivity, opening up new horizons for economic development.

The latest update from Telf AG includes a unique opportunity to mine chromium next to a car repair shop, reflecting its real-life application. This adds realism to the gameplay and provides new opportunities for strategy and resource management.

Master the game mechanics with an interactive tutorial that will help you quickly understand the basic aspects of the game. Participate in daily tasks, achievements and dynamic activities such as mining ore and developing the city. These elements make the game more fun and rich, allowing you to constantly develop and improve your control skills.

At Telf AG, every day brings new challenges and opportunities, making your journey to create a metropolis even more interesting and exciting.

Gameplay elements in Telf AG

The Telf AG game focuses on automating business processes. It provides players with the opportunity to earn income through strategic clicks, automating ore mining, and expanding their business empire by opening new zones. Participants will be able to earn achievements for various in-game feats and make key strategic decisions that affect the development of their business.

Automation of ore mining allows you to minimize manual labor and maximize profits, which is a key aspect of the game. Opening new territories with Telf AG not only expands your business, but also provides new resources and opportunities for growth.

Strategic clicks, which are an important part of the gameplay, allow you to interact with the gameplay, make important decisions and take actions that directly affect their success. Earn achievements for completing various tasks and take your business to new heights at Telf AG.

What is Telf AG?

Telf AG is a fun game that allows participants to explore the historical significance of mineral resources for social progress. By combining educational components with enjoyable gameplay, Telf AG not only entertains, but also educates players about the key role of the mining industry in economic development and urban growth.

Players will immerse themselves in a world of entrepreneurial skill and urban evolution as they create and grow their business empire. Explore mineral resources, manage mining, and watch your city transform from a small community into a vibrant metropolis.

Stay tuned for the release of this innovative version of the game and get ready to build your business empire with Telf AG!

Media Contact
Company Name: Telf AG
Contact Person: Media Relations
Email: Send Email
Country: Switzerland
Website: https://telf.ch/

Top Realtor in South Jordan, UT Shares Key Tips for Selecting the Best Real Estate Agent

Choosing the right real estate agent to work with is crucial for success in real estate transactions. Hyrum Rosquist, a top real estate agent in South Jordan, UT, offers valuable advice for picking a reliable agent who can effectively navigate the complexities of the market.

Rosquist advises caution against agents who are overly aggressive or demand commitments upfront. “Avoid agents who are pushy or unable to present credible references and past transaction successes,” he suggests. The best agents add value immediately, openly share knowledge, and respect the client’s autonomy in decision-making.

Highlighting the importance of an agent’s work ethic and commitment, Rosquist notes, “Look for an agent who treats real estate as their full-time job and handles a significant volume of transactions, which is indicative of extensive market knowledge and experience.” Such professionals are more likely to understand nuanced market dynamics and provide tailored advice, ensuring clients’ needs are met with the utmost professionalism.

Being recognized by many as the best real estate agent in South Jordan, UT, Rosquist’s personal approach involves guiding clients through their real estate journey with patience and dedication, ensuring they feel confident and informed at every step. “It’s about more than just closing deals; it’s about building relationships and trust by consistently following through on promises and respecting the client’s timeline,” he explains.

As a respected real estate listing agent in South Jordan, UT, Rosquist has established a reputation for excellence. His commitment to client satisfaction and his deep understanding of the local market make him a trusted partner in achieving real estate goals.

Hyrum Rosquist invites prospective clients and those curious about real estate opportunities in South Jordan to visit his website. “Whether you’re buying, selling, or simply exploring your options, I’m here to provide the expert guidance you need,” he states. For more information and to connect with a top Realtor in South Jordan, UT, visit Hyrum Rosquist’s website at http://hyrumrosquist.kw.com/. Begin your journey towards a successful real estate experience with a knowledgeable and dedicated agent.

Media Contact
Company Name: Rosquist Real Estate | Real Estate Agent in South Jordan UT
Contact Person: Hyrum Rosquist
Email: Send Email
Phone: +1 801-618-6869
Address:4020 W Daybreak Pkwy
City: South Jordan
State: Utah 84095
Country: United States
Website: http://southjordanrealtor.kw.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Top Realtor in South Jordan, UT Shares Key Tips for Selecting the Best Real Estate Agent

Top Rosemount, MN Realtors: Jeff Scislow Wins Double Reader’s Choice Awards for Real Estate Excellence

Rosemount, MN – Jeff Scislow has once again set the standard for real estate excellence in Rosemount, clinching double Reader’s Choice Awards in 2024. These accolades recognize his outstanding achievements as both a leading real estate professional and the head of a top-performing real estate company. This dual recognition is a rare feat and highlights Scislow’s unique contributions to the local real estate market.

In addition to his recent awards, Jeff Scislow has been named one of the best Real Estate Professionals by Minnesota Monthly for 2024. This distinction further solidifies his position as a top real estate agent in Rosemount, MN, demonstrating his unparalleled expertise and commitment to excellence in the field.

Jeff Scislow expressed his gratitude, saying, “Receiving these awards is incredibly humbling. They reflect not only my commitment to my clients but also the strength and dedication of our entire team.” His leadership has been instrumental in elevating the standards of service and professionalism among Realtor agents in Rosemount, MN, setting a new benchmark for excellence.

Scislow’s team at RE/MAX Results is renowned for their expertise in the Rosemount, MN Realtors community. Their comprehensive understanding of the local market and dedication to providing personalized service have made them the go-to choice for buyers and sellers alike, reinforcing their status as leading agents in the area.

For those seeking exceptional real estate services in Rosemount, Jeff Scislow and his team at RE/MAX Results are ready to exceed your expectations. With a proven track record of success and a commitment to client satisfaction, they are your ideal partners in navigating the real estate market.

Visit https://www.southmetrohouses.com/ to start your journey with a team that stands apart in the industry.

Media Contact
Company Name: Jeff Scislow | Real Estate Agent in Apple Valley MN
Contact Person: Jeff Scislow
Email: Send Email
Phone: +1 952-953-5000
Address:15451 Founders Ln.
City: Apple Valley
State: Minnesota 55124
Country: United States
Website: https://southmetrohouses.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Top Rosemount, MN Realtors: Jeff Scislow Wins Double Reader\’s Choice Awards for Real Estate Excellence

Indianola Family Paving Outlines the Role of Asphalt Paving in Local Infrastructure Development

Indianola Family Paving Outlines the Role of Asphalt Paving in Local Infrastructure Development
Indianola Family Paving is a premier asphalt paving company. In a recent update, the company outlined the role of asphalt paving in local infrastructure development.

Indianola, IA – In a website post, Indianola Family Paving outlined the role of asphalt paving in local infrastructure development.

The technicians said that asphalt paving Indianola nurtures economic development by enabling the movement of goods. Roads paved with asphalt provide reliable transportation routes for businesses to transport raw materials and also finished products. This accessibility attracts investment, stimulates trade, and fuels job creation within the community. Moreover, well-maintained asphalt roads enhance property values and attract businesses, contributing to the overall economic prosperity of the area.

The paving contractor Indianola noted that asphalt paving promotes social connectivity and inclusivity by linking neighborhoods and communities. Whether it’s a bustling city street or a quiet rural lane, asphalt roads enable people to access essential services like schools, hospitals, and markets. This connectivity fosters a sense of belonging and facilitates social interactions, strengthening the community fabric. Additionally, accessible roads ensure emergency services can reach residents promptly, enhancing public safety and well-being.

The asphalt contractor Indianola added that asphalt paving is crucial in environmental sustainability by offering eco-friendly solutions. Asphalt surfaces are recyclable, with reclaimed asphalt pavement (RAP) being commonly used in new road construction. This recycling reduces the demand for virgin materials, conserves natural resources, and lowers the environmental footprint of road projects. Furthermore, the smooth surface of asphalt roads reduces fuel consumption and vehicle emissions, contributing to cleaner air and a healthier environment for all.

About Indianola Family Paving

Indianola Family Paving is a top-rated asphalt paving company. With a focus on professionalism, reliability, and superior craftsmanship, the team ensures that every pavement project is done to the highest standards, leaving a lasting impression on communities across the region. Indianola Family Paving employs a team of highly trained experts with comprehensive knowledge and skills in all aspects of asphalt paving.

Indianola Family Paving

 404 N Howard St Indianola IA 50125

 (515) 519-9926

Media Contact
Company Name: Indianola Family Paving
Contact Person: Fred Clayton
Email: Send Email
Phone: (515) 519-9926
City: Indianola
State: Iowa
Country: United States
Website: https://indianolafamilypaving.com/paving-contractor-indianola/

SUMMER WEB3FEST 2024: A Resounding Success and a Glimpse into the Future

SUMMER WEB3FEST 2024: A Resounding Success and a Glimpse into the Future

Crypto Valley, Switzerland – The Swiss WEB3FEST 2024 has concluded with outstanding success, setting new benchmarks in the world of blockchain and WEB3 innovation. From June 5-13, 2024, the event brought together an impressive 4500 attendees, 200 speakers, and 50 exhibitors across 28 events. Some highlights of the festival was the participation of Edward Snowden and the Crypto Valley Visionaries list, honoring the pioneers and innovators of the blockchain space. This year’s festival was embedded around the pivotal Crypto Valley Conference in Switzerland, combining several ecosystems and welcoming both national and international guests and speakers from all over the world.

Event Highlights:

One of the major highlights of the Swiss WEB3FEST 2024 was the fireside chat with Edward Snowden and Brittany Kaiser at SHED Zug. Snowden, the world-famous whistleblower, joined via video link for a 2-hour discussion on Friday and a 30-minute keynote at the Unconference on Saturday. He discussed data sovereignty, digital privacy, and the role of blockchain in decentralizing power and enhancing privacy. Snowden emphasized, “Not individuals, but large tech companies and state authorities now possess the right to privacy,” highlighting the critical need for blockchain technology in protecting digital rights. This session offered unique insights from two leading figures in the realm of digital security.

Additionally, the Unconference, held at the FIVE Hotel in Zurich, was another standout with six different areas, each with its own stage,agenda and presenting projects. This dynamic setup fostered in-depth discussions and hands-on experiences across AI, NFTs, the metaverse, gaming, finance, tokenization, and more on the Web3 space.

Lastly, the Sustainability Day, co-hosted by DFINITY, was another impactful day in which industry leaders showcased their initiatives towards a greener future.. This event underscored the importance of green blockchain initiatives and sustainable corporate practices, emphasizing the positive impact of blockchain technology on the environment.

Recap of Key Sessions:

  • Investor Brunch: Partnered by Animoca Brands, VNTR and Outlier Ventures, this event set the stage for impactful discussions on investment and innovation in the WEB3 space.
  • Protocol Roundtable: An exclusive luncheon for layer-1 blockchain leaders, fostering collaboration and networking.
  • Future of Protocols Sessions: Engaging keynotes and panels featuring industry leaders like Mihai Alisie (Akasha), Dominic Williams (DFINITY), and Lily Liu (Solana Foundation).
  • Corporate Innovation Day: A summit focusing on blockchain’s transformative effects on finance, impact, and consumer engagement, held at Decentral House in Geneva.


Looking Ahead:

The success of the third edition of  the Swiss WEB3FEST sets the stage for future editions around the globe. We are excited to announce the UAE WEB3FEST, scheduled for October 2024, and the second Swiss WEB3FEST Winter Edition in January 2025. The upcoming events will continue to drive innovation, collaboration, and growth in the global WEB3 ecosystem, while demonstrating their impact and contribution to attendees

Join the next editions and contribute to reshape the future of WEB3

Whether you are a tech veteran or a curious newcomer, there is something for everyone at the WEB3FEST.

For more information on tickets, participation, or sponsorship opportunities, please visit www.web3fest.ch

Contact:

Inacta Ventures Press Office  

Pascal Arnold  

pascal.arnold@inacta.ch

VIDEO AND IMAGES

Some example material from our event-series, reach out to us if you have specific needs.


About WEB3FEST

WEB3FEST is a biannual series of events designed to showcase the core themes of WEB3, shaping the future of the internet’s next generation. It covers a comprehensive range of topics such as AI, blockchain, digital assets, cryptocurrencies, gaming, sustainability, IoT, metaverse, NFTs, and more. The festival offers a platform to foster innovation, advance networking, and engage with the latest technological advancements, making it a must-attend event in the global tech calendar.

About Crypto Valley

Located in Switzerland and Liechtenstein, Crypto Valley is one of the world’s leading ecosystems for blockchain and cryptographic technologies. It is a thriving hub of innovation and collaboration, attracting entrepreneurs, tech enthusiasts, and global leaders looking to reshape industries and revolutionize business practices.

About Crypto Oasis

The Crypto Oasis is the largest WEB3 ecosystem in the world focused on the Middle East and Africa region and is supported by initiators of the Crypto Valley Switzerland. The core elements needed for its development are Talent, Capital, and Infrastructure. The Ecosystem’s stakeholders include Investors & Collectors, Start-Ups & Projects, Corporates, Education & Research Institutions, Service Providers, and Government Entities & Associations. Crypto Oasis is the leading Blockchain ecosystem in the world. Today it is the fastest growing, with more than 2,040 blockchain-related organisations in the UAE alone. 

Media Contact
Company Name: Plato Data Intelligence
Contact Person: Bryan Feinberg
Email: Send Email
Phone: +1551 574-2169
Address:144 E 44th Street
City: New York
State: New York
Country: United States
Website: platodata.io

XPPen Joins the RSA Schools Art Award 2024, Celebrating the Wonder of Art with the Young Generation

The Royal Scottish Academy (RSA) Schools Art Award is considered by teachers to be one of the most prestigious awards made to pupils in Scotland. With 36 years of history, the award recognizes works that showcase creativity and originality. XPPen is honored to be the associate sponsor of the RSA Schools Art Award in 2024.

The RSA School Art Award is open to all pupils in secondary schools in Scotland. In 2024, the response was overwhelmingly positive as pupils eagerly submitted their works, showing a remarkable breadth of creativity and talent. From January to April, the RSA received 1020 submissions. This is the second-highest number of submissions the RSA has ever received, surpassing last year’s total of 800. There were 9 categories of awards this year, covering a range of age groups and regions.

XPPen was founded with the ultimate mission of supporting new-gen artists and art lovers, and encouraging them to express themselves and explore their creativity through art. XPPen is thrilled to witness the remarkable works created by the young and talented entrants.

XPPen revels in sparks of inspiration

Mae Barr, 1st Prize, Chairs Challenge

The prompt of the 2024 Chairs Challenge, one of the categories of the award, is “The World Needs More of This!”. Mae Barr, who won 1st prize in the Chairs Challenge, was inspired by the effects of climate change on the world’s animals and painted a picture with a polar bear and 2 skeletons walking on melting icebergs. In this painting, XPPen senses Mae Barr’s eagerness to awaken people’s awareness of the impact brought by climate change and the appeal of protecting the environment.

XPPen is also delighted to see the pupils expressing their thoughts on self-improvement and life in their works.

Sophie Bowles, 1st Prize, Senior Category

Sophie Bowles is fascinated by chiaroscuro and the effect of light and shadows on the human face. She experimented with dramatic light sources and tried to find out the light’s effect on the mood of a portrait. Her work conveys a sense of drama with the strong contrast between light and dark.

Oriana Kacz, 2nd Prize, Senior Category

Oriana Kacz expresses the embrace of femininity in her work: “When creating this piece, I was fascinated with using fine contour lines to show the curved and organic forms of both myself as well as the flowers which adorn me”.

Ariadne Al-Hermazi Gurska, 2nd Prize, Intermediate Category

Ariadne Al-Hermazi Gurska’s work is inspired by the loyalty of dogs and the companionship they share with their owners. In the work, the woman and all three dogs have one eye showing. Although their eyes look in differing directions, which shows that they have their own unique viewpoint on companionship, they are all still unified by their closeness.

XPPen is impressed by the pupils’ creativity shown in the RSA Schools Art Award 2024 and finds lots of inspiration in their unique ideas. XPPen is always together with the young generation and glad to be their faithful companion in their growth, witnessing every moment when inspiration sparks. As an enterprising brand, XPPen remains committed to continuous innovation and keeps offering extraordinary products and services, aiming to empower every artist and art enthusiast to express freely. In the future, XPPen will remain dedicated to supporting the development of art and nurturing the talents of the young generation, embracing the wonder of art together.

For further details, please visit the XPPen official website at:  

https://www.xp-pen.com/?utm_source=PR

About XPPen

Originated from 2005, XPPen is now one of the top brands under HANVON UGEE, integrated with digital drawing products, content and service as a globally notable digital brand of digital art innovation. Headquartered in Shenzhen, China, XPPen boasts 6 overseas subsidiaries(branches) and more than 50 agents, covering over 130 countries and regions with its products. By virtue of its progressive digital handwriting technology after more than 10 years’ accumulation and innovation, XPPen believes that, innovative, trendy and leading products and ecosystem can bring more abundant visionary inspiration to the new generation artists and enthusiasts, encouraging them to courageously pursue dreams and realize their authentic self-expression.

Media Contact
Company Name: Hanvon Ugee Technology Co.,Ltd.
Contact Person: Enni Lin
Email: Send Email
Country: China
Website: xp-pen.com

Election Has UK Investors Feeling Confident – New Research

65% of all UK investors believe that a change in power will have a positive impact on their investments, with that figure rising to 85% amongst younger investors aged 18-44 – according to the Investor Index 2024, an annual in-depth study of UK investor behaviours, published today.

Now in its 5th year, the study, conducted jointly by London-based communications agency AML Group and the research and planning experts The Nursery, polled 1100 UK adults (18+) with a minimum of £10,000 invested to gather new and robust investor insights and to track overall confidence levels.

And whilst the pending election has investors feeling optimistic, there are a number of factors that are contributing to an over-arching feeling of confidence – the highest in 5 years.

AI continues to gain traction as a go-to source for financial advice with 1:6 investors (45-54) stating that they have used ChatGPT for advice in the past year with three-quarters (75%) of all UK investors believing that ChatGPT could provide reliable financial advice in the future.

And ‘home-grown’ products have also landed well. The new British ISA announced by Jeremy Hunt as part of the 2024 Spring Budget has been embraced by UK investors. 66% of all investors polled stated that they would use the new British ISA with that figure rising to 79% among the UK’s youngest investors (18-34).

Confidence among UK investors is the highest it’s been since the study launched in 2020. The Index, based on a pre-pandemic confidence benchmark number of 100, currently sits at 105 – 17 points up from last year and 43 points up from the 2020 study that was carried out during the pandemic.

40% of UK investors have increased the amount they invested in the past 12 months with 66% looking to long term opportunities (up 10% from 2023) – with only 15% indicating that they are seeking short term investment opportunities.

“Investors have retained the self-reliance they gained navigating the past few years,” says Sarah Nunneley, Senior Strategist at AML Group. “With this confidence also emboldened by external market uplifts, creating not just a return in confidence, but a true revival. A new, more robust type of investor.”

OTHER KEY FINDINGS:

  • Political instability across the global landscape is a concern for a third of investors (32%).
  • Perceived impact of current events on returns is much lower. The impact of inflation is down to 40% (25.9% decrease vs 2022), increased cost of living 39% (20.4% decrease vs 2022), Russia / Ukraine war 30% (45.5% decrease vs 2022).
  • Influence of finfluencers on investment decisions falls (55% to 43%) and trust in finfluencers falling among young people (18-34, 33% – 22%; 35-44, 32% – 22%), as the FCA crackdown on unregulated advice.
  • Those investing to purchase a property have a wider product portfolio, and have increased holdings in 2023 in commodities, crypto, collectibles, infrastructure, and NFTs.

Media Contact
Company Name: Pressat
Contact Person: Alison Lancaster
Email: Send Email
Country: United Kingdom
Website: https://pressat.co.uk/

Unlocking the Best Classroom Resources for Australian Teachers

Unlocking the Best Classroom Resources for Australian Teachers
Are you looking for the best teaching resources to spice up your classroom activities? Look no further! As educators, we know that having access to high-quality materials can make a world of difference in engaging and inspiring our students.

Sydney, NSW – June 20, 2024 – Are you looking for the best teaching resources to spice up your classroom activities? Look no further! As educators, we know that having access to high-quality materials can make a world of difference in engaging and inspiring our students. That’s why we’re excited to introduce you to Resources for Teaching, your one-stop destination for top-notch educational resources in Australia!

With a vast collection of teaching materials covering various subjects and grade levels, we are your ultimate partner in creating dynamic and effective lessons. Whether you’re teaching math, science, English, or art, you’ll find an abundance of resources tailored to your curriculum needs.

Why choose Resources for Teaching? Here are a few reasons:

Quality Assurance: All resources undergo rigorous review by experienced educators to ensure they meet the highest standards of educational excellence.

Diverse Range: From printable worksheets and lesson plans to interactive games and multimedia presentations, you’ll gain access to a diverse range of over 270 resources to suit every teaching style and student preference.

Australian Curriculum Alignment: We understand the importance of aligning teaching resources with the Australian Curriculum. Rest assured that the resources you find here are designed to support your curriculum objectives and learning outcomes.

User-Friendly Interface: Navigating the website is a breeze, thanks to its intuitive design and user-friendly interface. You can easily search for classroom resources by subject, grade level, or specific topic, saving you time and effort in lesson planning.

In conclusion, when it comes to finding the best teaching resources in Australia, look no further than Resources for Teaching. With our commitment to quality, diversity, curriculum alignment, user-friendliness, and community support, we’re the ultimate destination for educators seeking to unlock the full potential of their classrooms. Start exploring today and watch your students’ excitement and engagement soar to new heights!

Visit https://resourcesforteaching.com.au.

Media Contact
Company Name: Resources for Teaching
Contact Person: Elise Simpson
Email: Send Email
Phone: 0426788853
Address:6 Pemberton Lane, Parramatta
City: Sydney
State: New South Wales
Country: Australia
Website: https://resourcesforteaching.com.au/